sign up for retatrutide trial New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Lilly's 'triple G' agonist triumphs

Patents in the US remain in place until the late 2020s at the earliest

Elevated TMAO levels have been associated with increased risks of atherosclerosis, cardiovascular disease, and higher all-cause mortality in multiple epidemiological studies

Compounded medications are not FDA-approved and may differ from FDA-approved drugs in safety and effectiveness

It has been shown to stimulate the release of brain-derived neurotrophic factor (BDNF), a protein that plays a crucial role in the survival of neurons and the growth of new neurons and synapses

administration of LEGEND in 46 horses

d) Distribution of the BMI % phenotype